The outpatient prescription drug market, which was slow in winter, is showing a recovery trend. Since the end of last year, the total prescription drug volume has been on a decline compared to the previous year, but in March it turned to an upward trend. It is analyzed that COVID-19 showed sluggishness due to a sharp decline in infectious disease patients due to the prolonged aftermath of the prolonged aftermath, but rebounded at the end of the flu season.

According to the drug research institute UBIST on the 18th, the total outpatient prescription amount in the first quarter of the year was ₩3.5697 trillion, down 3.6% from the same period last year. Compared to the first quarter of 2019, it also dec